When the Detroit Tigers’ season ended in heartbreaking fashion against Seattle, Gleyber Torres didn’t just pack up his locker—he revealed the pain he’d been hiding for months. The All-Star second baseman announced he would undergo sports hernia surgery, finally addressing the injury that quietly derailed both his performance and, arguably, Detroit’s playoff push.
A Hidden Injury Behind the Numbers
For much of 2025, Torres looked like the player who once electrified Yankee Stadium—confident, consistent, and clutch. Through the first half of the season, he hit .281 with a .387 on-base percentage and an impressive .425 slugging mark. Those numbers earned him the American League’s starting nod at second base in the All-Star Game, reaffirming his reputation as one of baseball’s most complete middle infielders.
But after the break, his production nosedived. Over his final 269 plate appearances, Torres slashed just .223/.320/.339—a steep drop that mirrored Detroit’s own late-season collapse. The Tigers, once a division leader, stumbled to a 9-22 finish, clinging to the final wild card spot before bowing out in the ALDS.
Torres admitted he played through “a lot of pain” during the second half. While he credited Detroit’s medical staff for keeping him on the field, the reality was that the sports hernia sapped his power and mobility. His swing mechanics looked stiffer, his lower half less explosive. For a hitter whose success relies on core rotation and torque, even a mild hernia can dramatically alter results.
That mechanical limitation may explain his diminished slugging percentage and occasional lapses in fielding range. Despite improved defensive metrics compared to his final year in New York, Torres still struggled to make the same lateral bursts he showed early in the season. The mental fatigue of pushing through pain likely compounded the issue, as each game became an exercise in endurance rather than execution.
Impact on Free Agency and the Road Ahead
Torres’ decision to play through the injury wasn’t just about toughness—it was about opportunity. On a one-year, $15 million “pillow deal” with Detroit, the 28-year-old infielder was looking to reestablish his market value heading into free agency. Instead, the second-half slump clouded what could have been a breakout campaign.
Still, his full-season line of .256/.358/.387 with 16 homers and 2.6 fWAR placed him among the top eight second basemen in baseball. With free agency looming, Torres’ surgery—and subsequent recovery timeline—now becomes a major subplot. Sports hernia procedures typically require 8–12 weeks of recovery, meaning he should be ready by Spring Training if rehab progresses smoothly.
That timeline may reassure front offices, especially those seeking a proven right-handed bat at a thin position. Torres’ representatives at Octagon will undoubtedly argue that his first-half production represents the “real” version of their client, not the injury-plagued second half that dragged down his numbers.
As for Detroit, a reunion isn’t off the table. Torres has publicly stated his desire to stay, calling the Tigers’ 2025 campaign “really special.” Retaining him would maintain balance in their lefty-heavy lineup and provide veteran leadership for a young core that includes Spencer Torkelson and rising prospect Kevin McGonigle.
Whether in Motown or elsewhere, Torres’ 2025 season now reads differently—not as a decline, but as a testament to endurance. His surgery closes one painful chapter but opens another: the chance to show baseball what a fully healthy Gleyber Torres can still become.
Like Heavy Sports’s content? Be sure to follow us.
This article was originally published on Heavy Sports
The post Tigers Infielder’s Mystery Slump Finally Has an Explanation appeared first on Heavy Sports.